News for Divi's Laboratories Limited (DIVISLAB.BO)

The Nifty Pharma index was trading 0.8 per cent up at 19978.6.

The Nifty Pharma index closed 0.24 per cent down at 20201.25.

The Nifty Pharma index was trading 0.61 per cent down at 20125.55.

The analysis revealed that nearly 96% (255) of low beta stocks have dropped by double digits from their 52-week peak, with 5% (13 stocks) falling over 50%.

The Nifty Pharma index closed 0.02 per cent up at 20389.7.

The Nifty Pharma index closed 1.92 per cent down at 20385.65.

The Nifty Pharma index was trading 1.36 per cent down at 20503.85.

The Nifty Pharma index closed 0.16 per cent down at 20785.75.

The Nifty Pharma index closed 0.71 per cent down at 20820.0.

The Nifty Pharma index was trading 0.67 per cent down at 20828.3.

The Nifty Pharma index closed 0.51 per cent down at 21142.05.

The Nifty Pharma index closed 1.92 per cent down at 21249.5.

The Nifty Pharma index was trading 1.86 per cent down at 21665.65.

Feb 03, 2025 / 09:30AM GMTOperator Ladies and gentlemen, good day, and welcome to the conference call of Divi's Laboratories Limited for Q3 FY25. (Operator Inst

The Nifty Pharma index closed 0.64 per cent up at 22009.05.

The Nifty Pharma index closed 1.74 per cent up at 21733.95.

Divi's Labs surged 6% after reporting a 64% YoY profit jump in Q3FY25. Revenue rose 25% YoY to Rs 2,319 crore. Goldman Sachs stays Neutral (target: Rs 5,925), while Nuvama maintains Buy (target: Rs 6,830) citing strong growth potential.

Stocks including Coal India, Lupin, Power Grid, Indian Bank, Happiest Minds, GR Infraprojects, Anant Raj, MOIL and more will be in the spotlight on Monday, February 03.

The Nifty Pharma index closed 0.09 per cent up at 21438.6.